ImmunityBio is a pioneering brand dedicated to conquering cancer and revolutionizing disease treatment. They develop innovative therapies that target and kill diseases while preserving the immune system. ImmunityBio's range of products includes investigational immunotherapy and cell therapy options.

Their immunotherapy treatments reinforce the patient's natural immune system, enabling it to outsmart the disease and eliminate cancerous or infected cells. ImmunityBio goes beyond conventional cancer therapies, such as radiation and chemotherapy, which can weaken the immune system. They have developed personalized immunotherapies that aim to strengthen the immune system to combat various types of cancer.

In addition, ImmunityBio conducts cutting-edge research and clinical trials in collaboration with the National Cancer Institute. They are focused on preventing cancer and advancing treatment options for difficult diseases like bladder cancer and pancreatic cancer. Their unique approach harnesses the power of the immune system's innate and adaptive functions, making their immunotherapy more promising than other treatment methods.

Overall, ImmunityBio is at the forefront of immunotherapy, working tirelessly to develop smart solutions that outsmart diseases and offer hope for patients worldwide